H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration
Companies Advance Multiple Co-discovery Programs for First-in-class Targets in Oncology
27-May-2014
- USA
H3 Biomedicine will provide a milestone to Selvita in consideration of Selvita’s achievement of the first research goal in the project. The companies are not disclosing the amount.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.